Breaking News

CDMO Great Bay Bio Founded

To build platform for CMC technology and pre-clinical R&D; names Michael Chan as CEO

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Great Bay Bio, a new biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical development of big data service platform, has been established in Hong Kong.   Dr. Michael Chan has been named chief executive officer. He will be tasked with formulating a sustainable development strategy for Great Bay Bio and be responsible for the overall operation and management of the enterprise. The headquarters will be based in Hong Kong and expand its busine...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters